SUMMARY Membrane receptors for IgG and C3b were examined on blast cells from 57 cases of acute myeloid leukaemia. These acute leukaemias were classified as myeloblastic, myelomonocytic or monocytic following morphological, cytochemical, and immunological investigations. The membrane receptors of leukaemic blast cells appear to be directly related to the degree of monocytic differentiation with the lowest receptor activities found in acute myeloblastic leukaemia. A comparison was also made between receptor and cytoplasmic acid naphthyl acetate esterase (ANAE) activities in 29 morphologically and immunologically-defined myelomonocytic and monocytic leukaemias. This study revealed that the receptor-positive "monocytic component" in a significant proportion of cases showed unexpectedly weak or negative ANAE reactions suggesting a more cautious approach to the interpretation of ANAE cytochemistry in acute leukaemias. The normal development of cytoplasmic ANAE and membrane receptors is also discussed and compared with their abnormal patterns of expression associated with leukaemic transformation.
The morphological classification of lymphoblastic leukaemias has been generally superseded by those based upon immunological characteristics.1-3 The lack of specific myeloid markers has, however, meant that the classification of acute non-lymphoid leukaemias has been largely dependent on morphological and cytochemical investigations.
Previous reports indicate that leukaemic monocytes in acute myelomonocytic and monocytic leukaemias have membrane receptors for IgG or complement, or both45 while the percentages of receptor-positive normal granulocyte precursors are relatively low. 67 We have examined membrane IgG and C3b receptors in 57 cases of acute myeloid leukaemia which were classified as myeloblastic, myelomonocytic or monocytic following morphological, cytochemical and immunological investigations. In addition, the membrane receptor characteristics and cytoplasmic esterase cytochemistry of leukaemic monocytes were compared for their value in further subclassifying acute leukaemias of myeloid origin.
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